Loading...
XSHG
688108
Market cap1.21bUSD
Jul 10, Last price  
19.39CNY
1D
-0.92%
1Q
-11.50%
IPO
2.76%
Name

Sino Medical Sciences Technology Inc

Chart & Performance

D1W1MN
XSHG:688108 chart
P/E
171.38
P/S
15.42
EPS
0.11
Div Yield, %
Shrs. gr., 5y
0.95%
Rev. gr., 5y
9.92%
Revenues
525m
+14.53%
265,614,219322,004,651380,422,071435,913,438327,419,971194,356,080192,854,227343,257,734458,739,270525,407,900
Net income
47m
+3,057.07%
28,650,46666,145,81689,190,37990,037,85122,493,246-130,765,688-162,381,783-39,630,0391,497,79247,286,300
CFO
162m
+23.34%
42,244,31370,322,85497,562,212137,605,14170,512,7540056,839,863131,240,036161,874,348
Dividend
Jul 10, 20200.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sino Medical Sciences Technology Inc. operates as a medical device enterprise, specializing in the research, development, manufacturing, and distribution of interventional medical devices throughout China. Its product portfolio features a range of crucial items, including drug-eluting stents, balloon catheters, coronary stents, and sophisticated transcatheter mitral valve replacement devices. Furthermore, the company maintains a clinical partnership with The National University of Ireland Galway. Established in 2007, its main operational base is situated in Tianjin, China.
IPO date
Oct 30, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT